Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 2/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10315682 | 1.00 | L3MBTL1 (0.42) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL10315683 | 0.99 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17539875 | 0.96 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17539872 | 0.96 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17539877 | 0.95 | L3MBTL1 (0.46) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL22352551 | 0.94 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL31670 | 0.93 | L3MBTL1 (0.49) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL10315685 | 0.92 | L3MBTL1 (0.36) | L3MBTL1ATMKDM4EKMT2ATSPO | |
| SCHEMBL16675127 | 0.91 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL10315678 | 0.91 | L3MBTL1 (0.40) | L3MBTL1ATMKDM4EKMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9450192-B2 | Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof | E-RAY OPTOELECTRONICS TECHNOLOGY (TW) | 2016-09-20 | — | — | US | disclosed |
| US-9450192-B2 | Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof | E-RAY OPTOELECTRONICS TECHNOLOGY (TW) | 2016-09-20 | — | — | US | disclosed |
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120175598-A1 | CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICES UTILIZING THE SAME AND FABRICATION METHOD THEREOF | AHR, ARNT, NAT1 | L3MBTL1 2732/4885ATM 2102/4885KDM4E 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.